Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 4

N8. Health Care-Associated Infections: C. difficile

Session: Challenges in C. difficile

19 - The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial

On Demand
Participants should be aware of the following financial/non-financial relationships:
Elizabeth Hohmann, MD: Seres Therapeutics (Research Grant or Support)
Paul Feuerstadt, MD, FACG: Ferring/Rebiotix Pharmaceuticals (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Finch Pharmaceuticals (Scientific Research Study Investigator)Merck and Co (Speaker's Bureau)SERES Therapeutics (Consultant, Scientific Research Study Investigator)Takeda Pharmaceuticals (Consultant)
Caterina Oneto, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Charles Berenson, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christine Lee, MD, FRCPC: Pfizer (Board Member)Rebiotix-Ferring (Board Member)Rebiotix-Ferring (Grant/Research Support)Seres (Grant/Research Support)Summit (Grant/Research Support)
Sissi Pham, PharmD: Seres (Consultant)
Lei Zhu, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Pat Ray Reese, PhD: Reese Associates, LLC (Consultant, Independent Contractor)
Henry Wu, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Elaine E. Wang, MD: Seres Therapeutics (Employee)
Lisa von Moltke, MD: Seres Therapeutics (Employee, Shareholder)
Kevin W. Garey, Pharm.D., M.S., FASHP: Summit Therapeutics (Research Grant or Support)

    Co-Author(s)

  • EH

    Elizabeth Hohmann, MD

    Massachusetts General Hospital
    Boston, Massachusetts, United States

    Seres Therapeutics (Research Grant or Support)

  • PF

    Paul Feuerstadt, MD, FACG

    Yale University School of Medicine/PACT-Gastroenterology Center
    Westport, Connecticut, United States

    Ferring/Rebiotix Pharmaceuticals (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Finch Pharmaceuticals (Scientific Research Study Investigator)Merck and Co (Speaker's Bureau)SERES Therapeutics (Consultant, Scientific Research Study Investigator)Takeda Pharmaceuticals (Consultant)

  • CO

    Caterina Oneto, M.D.

    NYU Langone
    New York, New York, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • CB

    Charles Berenson, MD

    Associate Professor of Medicine
    State University of New York at Buffalo
    Buffalo, New York, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • CL

    Christine Lee, MD, FRCPC

    University of British Columbia
    Victoria, British Columbia, Canada

    Pfizer (Board Member)Rebiotix-Ferring (Board Member)Rebiotix-Ferring (Grant/Research Support)Seres (Grant/Research Support)Summit (Grant/Research Support)

  • SP

    Sissi Pham, PharmD

    AESARA
    Chapel Hill, North Carolina, United States

    Seres (Consultant)

  • LZ

    Lei Zhu, PhD

    Aesara
    Chapel Hill, North Carolina, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • PR

    Pat Ray Reese, PhD

    Aesara, Inc.
    Apex, North Carolina, United States

    Reese Associates, LLC (Consultant, Independent Contractor)

  • HW

    Henry Wu, PhD

    CR Medicon Research
    Piscataway, New Jersey, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • EW

    Elaine E. Wang, MD

    Sr. Medical Director
    Seres Therapeutics
    Cambridge, Massachusetts, United States

    Seres Therapeutics (Employee)

  • Lv

    Lisa von Moltke, MD

    Seres Therapeutics
    Cambridge, Massachusetts, United States

    Seres Therapeutics (Employee, Shareholder)

    • Presenting Author(s)

  • Kevin W. Garey, Pharm.D., M.S., FASHP

    Professor
    University of Houston College of Pharmacy
    Houston, TX, United States

    Summit Therapeutics (Research Grant or Support)

    Slides Slides and Audio